Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Superiority Study of Model-Guided Optimized Dosing Versus Empirical Dosing of Piperacillin/Tazobactam in the Treatment of Community-Acquired Pneumonia in Elderly Patients
Sponsor: Shandong University
Summary
This study tests a new way to give an antibiotic to older adults with pneumonia. Pneumonia is a lung infection. Piperacillin-tazobactam is an antibiotic. Doctors often use it to treat pneumonia in older adults. Right now, doctors usually give this drug every 8 hours. They let it drip into the vein over 3 hours. But early research suggests a different schedule may work better. This study will test giving the drug every 6 hours. The drip will last 4 hours. Researchers think this may help the drug fight germs better. The study will compare the usual schedule with the new schedule. Participants will join one of two groups. One group will get the usual schedule. The other group will get the new schedule. Researchers will check how well the drug works. They will also watch for side effects. They want to find the safest and most helpful way to give this drug. Adults aged 65 and older with community-acquired pneumonia can join. Community-acquired pneumonia is a lung infection that starts outside of a hospital.
Official title: A Randomized Superiority Study Comparing Model-Guided Optimized Dosing With Empirical Dosing of Piperacillin/Tazobactam in Elderly Patients With Community-Acquired Pneumonia
Key Details
Gender
All
Age Range
65 Years - 110 Years
Study Type
INTERVENTIONAL
Enrollment
118
Start Date
2026-07-17
Completion Date
2027-05-31
Last Updated
2026-11-18
Healthy Volunteers
No
Interventions
Piperacillin Sodium and Tazobactam Sodium for Injection (Bangda®)
Control arm (guideline-based conventional dosing): Piperacillin Sodium and Tazobactam Sodium for Injection (Bangda®) 4500 mg administered as a 3-hour intravenous infusion every 8 hours (q8h), for a total treatment course of 5-14 days.
Piperacillin Sodium and Tazobactam Sodium for Injection (Bangda®)
Intervention arm (model-guided optimized dosing): Piperacillin Sodium and Tazobactam Sodium for Injection (Bangda®) 4500 mg administered as a 4-hour intravenous infusion every 6 hours (q6h), for a total treatment course of 5-14 days. This arm adopts increased dosing frequency and prolonged infusion duration compared with the control arm.
Locations (1)
Shandong Provincial Public Health Clinical Center
Jinan, Shandong, China